Regulatory · source year

2015 regulatory records

24 selected, source-linked regulatory records dated 2015. This is selective source coverage, not a complete timeline.

Dated records

24 selected records.

Peptide profiles

12 connected profiles.

Cited sources

24 distinct public records.

Cited chronology

Dated source records

All record types in 2015 →

December 2015

4 records

Glatiramer acetate

Federal Register proposed rule 2015-32246

The Federal Register published proposed rule 2015-32246, attributed to FDA and its parent HHS department, on 2015-12-23. Its official title is “Fixed-Combination and Co-Packaged Drugs: Applications for Approval and Combinations of Active Ingredients Under Consideration for Inclusion in an Over-the-Counter Monograph,” and PeptideScanner's exact reviewed identity mapping connects the document to Glatiramer.

Source: Federal Register via GovInfo ↗

→

November 2015

1 record

September 2015

1 record

Glucagon

Federal Register notice 2015-22673

The Federal Register published notice 2015-22673, attributed to FDA and its parent HHS department, on 2015-09-09. Its official title is “Determination That GLUCAGON (Glucagon Hydrochloride) for Injection, Equivalent to 1 Milligram Base/Vial and Equivalent to 10 Milligram Base/Vial, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon.

Source: Federal Register via GovInfo ↗

→

July 2015

2 records

June 2015

3 records

May 2015

5 records

Pasireotide

Federal Register notice 2015-10994

The Federal Register published notice 2015-10994, attributed to FDA and its parent HHS department, on 2015-05-07. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; SIGNIFOR,” and PeptideScanner's exact reviewed identity mapping connects the document to Pasireotide.

Source: Federal Register via GovInfo ↗

→

Teduglutide

Federal Register notice 2015-11000

The Federal Register published notice 2015-11000, attributed to FDA and its parent HHS department, on 2015-05-07. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; GATTEX,” and PeptideScanner's exact reviewed identity mapping connects the document to Teduglutide.

Source: Federal Register via GovInfo ↗

→

Triptorelin

Federal Register notice 2015-11003

The Federal Register published notice 2015-11003, attributed to FDA and its parent HHS department, on 2015-05-07. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; OVUGEL,” and PeptideScanner's exact reviewed identity mapping connects the document to Triptorelin.

Source: Federal Register via GovInfo ↗

→

April 2015

2 records

Oxytocin

Federal Register notice 2015-09299

The Federal Register published notice 2015-09299, attributed to FDA and its parent HHS department, on 2015-04-22. Its official title is “Determination That OXYTOCIN in 5% Dextrose Injection Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Oxytocin.

Source: Federal Register via GovInfo ↗

→

March 2015

3 records

January 2015

3 records